<DOC>
	<DOC>NCT01384409</DOC>
	<brief_summary>To evaluate the efficacy and safety of KW-3357 with concomitant use of heparin using multi-center, non-comparative, open-label method in patients diagnosed as disseminated intravascular coagulation (DIC) by Japanese Association for Acute Medicine-defined DIC criteria.</brief_summary>
	<brief_title>A Phase 3 Clinical Study of KW-3357 in Patients With DIC</brief_title>
	<detailed_description />
	<mesh_term>Disseminated Intravascular Coagulation</mesh_term>
	<criteria>Japanese Association for Acute Medicinedefined DIC criteria score &gt;= 4 Antithrombin activity &lt;= 70% Written informed consent from patient or guardian Anamnesis or complication of serious drug allergy Serious liver disorder, such as fulminant hepatitis and decompensated cirrhosis Pregnant, nursing, or possibly pregnant woman Possibility for the promotion of bleeding by concomitant use of heparin</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>